The company history of PANACEO
From the first encounter with the natural mineral zeolite to the patented PMA zeolite: the story of a Carinthian family business.
Who is behind PANACEO?
As a health-conscious person, it was both the fascination and the traditional hypotheses regarding potential areas of application that prompted me many years ago to take a closer look at the natural mineral zeolite-clinoptilolite.
My personal insights, the application experiences within my immediate circle, and the positive feedback from doctors I know encouraged me to research the natural mineral in greater depth. As a family business, we have been bringing our medical devices to market under the brand name PANACEOsafely and with certification for our customers since 2006.
Our health is the foundation of our lives
We must preserve it for as long as possible in order to prevent or alleviate illnesses that limit us. Zeolite – a gift of nature – offers, in today’s world awash with disease-causing poisons and pollutants, a hitherto unique opportunity to carry more health into one’s personal future.
From raw material to PMA zeolite
For almost 20 years, my great team, the PANACEO family, has been working on the unique properties and the optimisation of the raw material which, after the patented PANACEO micro-activation method, is referred to as PMA zeolite.
PANACEO cooperates with international doctors and experts from a wide range of medical specialties. The result of years of extensive research makes PANACEO, with its medical devices based on PMA zeolite, the absolute market leader in terms of quality, safety and efficacy.
A large number of studies confirms the positive effects and thus clearly sets PANACEO apart from dubious zeolite providers.
In addition, we produce high-quality food supplements under the GREEN HEALTH brand, and the CARE natural cosmetics line is also part of the PANACEO product range. Product quality and a focus on natural ingredients are paramount.
Look forward to a healthy future with PANACEO.
Key milestones
The first encounter
First encounter with the natural mineral zeolite-clinoptilolite and with the entrepreneur and inventor Jakob Hraschan.
First studies
Initiation and funding of initial studies, including an OECD-compliant toxicity test.
Development of the PMA activators
Research, design and production of the PMA activators for the refinement and optimisation of the raw material.
Observational use
Broadly based observational use in hundreds of patients in cooperation with complementary medicine practitioners.
Company founded in Carinthia
Founding of Panaceo International GmbH at the Gödersdorf site near Villach.
Approval as a medical device
Approval as a medical device to ensure the described efficacy and safety for the user.
Awareness and liver research
Launch of Austria-wide marketing and awareness-raising activities for end customers and professionals. Research into pollutant binding in the gastrointestinal tract. Conduct of a non-interventional study (NIS) on liver health.
Double-blind study on the intestinal wall barrier
Publication of a randomised, placebo-controlled double-blind study (gold standard) on the effective strengthening of the intestinal wall barrier.
Safety and efficacy
Research and publication of safety- and efficacy-relevant studies on the effect of PMA zeolite.
Tolerability of medicinal therapies
Publication of a gold-standard study to support the tolerability of medicinal therapies.
Alleviation of intestinal inflammation
Publication of a gold-standard study on the effective alleviation of intestinal inflammation.
Bone metabolism and oncology
Long-term publication on the improvement of bone metabolism and fracture probability in osteoporosis over five years of observation. Follow-up publication supporting the tolerability of medicinal therapies with a focus on oncological parameters.